STOKE THERAPEUTICS INC shareholders Q2 2023

STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 100 filers reported holding STOKE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.06 and the average weighting 0.8%.

STOKE THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
VIRGINIA RETIREMENT SYSTEMS ET AL 15,600$165,8280.00%
Connor, Clark & Lunn Investment Management Ltd. 45,575$484,4620.00%
PRICE T ROWE ASSOCIATES INC /MD/ 358,922$3,8160.00%
Renaissance Technologies 42,300$4500.00%
RHUMBLINE ADVISERS 42,175$448,3200.00%
BlackRock Inc. 2,293,670$24,381,7110.00%
GEODE CAPITAL MANAGEMENT, LLC 599,780$6,375,6610.00%
Ameritas Investment Partners, Inc. 2,278$24,2150.00%
NORTHERN TRUST CORP 268,135$2,850,2740.00%
D. E. Shaw & Co., Inc. 116,465$1,238,0230.00%
METROPOLITAN LIFE INSURANCE CO/NY 1,515$16,1040.00%
TWO SIGMA INVESTMENTS, LP 20,500$217,9150.00%
MetLife Investment Management, LLC 14,616$155,3680.00%
AMERICAN INTERNATIONAL GROUP, INC. 13,277$141,1350.00%
DIMENSIONAL FUND ADVISORS LP 340,145$3,615,3640.00%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 206,891$2,199,2510.00%
Citadel Advisors 12,600$133,9380.00%
Allspring Global Investments Holdings, LLC 14,934$158,7480.00%
Beaird Harris Wealth Management, LLC 38$4040.00%
JPMORGAN CHASE & CO 23,167$246,2650.00%
External links

This page lists STOKE THERAPEUTICS INC's shareholders in Q2 2023. To view STOKE THERAPEUTICS INC's shareholder history, click here.